Sun Hong-Quan, Zhou Zhan-Yu
Department of Ophthalmology, the Affiliated Hospital of Medical College of Qingdao University, Qingdao 266003, Shandong Province, China.
Int J Ophthalmol. 2010;3(3):220-3. doi: 10.3980/j.issn.2222-3959.2010.03.09. Epub 2010 Sep 18.
To investigate the effect of ginsenoside-Rg3 on the expression of vascular endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α) in retina with diabetic rats and its roles in preventing neovascularization in diabetes.
Sixty male Wistar rats were divided into 3 groups randomly: negative control group, diabetic control group and ginsenoside-Rg3 treatment group (5mg/kg, 0.2mg/mL) followed by establishing diabetic model. The expression of VEGF and TNF-α were measured after 8 weeks.
There were significant differences among negative control group, diabetic control group and ginsenoside-Rg3 treatment group in the expression of VEGF and TNF-α (F=129.363, 211.992; all the P<0.01). VEGF and TNF-α expression were significantly higher in diabetic control group and ginsenoside-Rg3 treatment group than that in negative control group (P<0.01), with a significant reduction in ginsenoside-Rg3 treatment group than that in diabetic control group (P<0.01).
Ginsenoside-Rg3 can down-regulate the expression of VEGF and TNF-α in retina, which may interfere in the development of diabetic retinopathy.
探讨人参皂苷-Rg3对糖尿病大鼠视网膜血管内皮生长因子(VEGF)和肿瘤坏死因子-α(TNF-α)表达的影响及其在预防糖尿病新生血管形成中的作用。
60只雄性Wistar大鼠随机分为3组:阴性对照组、糖尿病对照组和人参皂苷-Rg3治疗组(5mg/kg,0.2mg/mL),随后建立糖尿病模型。8周后检测VEGF和TNF-α的表达。
阴性对照组、糖尿病对照组和人参皂苷-Rg3治疗组之间VEGF和TNF-α的表达有显著差异(F=129.363,211.992;均P<0.01)。糖尿病对照组和人参皂苷-Rg3治疗组中VEGF和TNF-α的表达显著高于阴性对照组(P<0.01),人参皂苷-Rg3治疗组较糖尿病对照组显著降低(P<0.01)。
人参皂苷-Rg3可下调视网膜中VEGF和TNF-α的表达,这可能会干扰糖尿病视网膜病变的发展。